Fia Yi, MD
Colon & Rectal Surgery · Athens, GANPI 1255542494
Payments from drug & device makers
What this record shows
This record is dominated by education: $21,000 of the $31,751 with a category attached, or 66.1%. Intuitive Surgical accounts for 92.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $16,725 and has fallen 73.0% since, to $4,512 in 2025.
Across 92 payments — averaging $345.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$29K
- Applied Medical Resources Corporation$1K
- Medtronic$403
- Johnson & Johnson$141
- Conmed Corporation$115
- Merck$100
- plus $504 from 21 others
What the payments were for
- Speaking & faculty fees$5,00016%
- Travel & lodging$2,2897%
- Food & beverage$3,46211%
- Education$21,00066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 43 | $29,487 |
| Applied Medical Resources Corporation | 1 | $1,000 |
| Medtronic(2 entities) | 9 | $403 |
| Johnson & Johnson(2 entities) | 6 | $141 |
| Conmed Corporation | 2 | $115 |
| Merck | 4 | $100 |
| Stemline Therapeutics Inc. | 4 | $87 |
| Daiichi Sankyo Inc. | 2 | $39 |
| GSK | 2 | $33 |
| Smith+Nephew | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Coloplast | 1 | $24 |
| Seagen Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Bayer | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| Incyte Corporation | 1 | $17 |
| Genmab U.S., Inc. | 1 | $16 |
| ADC Therapeutics America, Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $14 |
| Morphosys, US Inc. | 1 | $13 |
| Blueprint Medicines Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$28,813
- GI Genius$139
How this compares
$31,751 in reported general payments places this provider in the 85th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 57 | $293 |
| Oxycodone Hcl | 58 | $209 |
| Ondansetron OdtOndansetron | 14 | $116 |
| Metronidazole | 62 | $112 |
| Tramadol Hcl | 23 | $53 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Athens
- Thomas WardAthens$2K
- Gregory DelaurierAthens$1K
- Ashlee KimbrellAthens$596
- David ArmstrongLawrenceville$1.2M
- Jeffrey CohenMarietta$663K
- Erin King-MullinsMacon$119K
- Jay SinghRoswell$102K
- Jason PetrofskiCumming$74K
- Dennis ChoatFayetteville$65K
- Seth RosenJohns Creek$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.